Vivos Therapeutics (VVOS) EBIT Growth (3y) (2023 - 2026)
Vivos Therapeutics (VVOS) EBIT Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 13.06% |
| 10 | Vivos Therapeutics | 4.96 Mn | 3.16 Mn | 2.95 Mn | -2.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.74% |
| Dec 31, 2025 | -1.72% |
| Sep 30, 2025 | 4.33% |
| Jun 30, 2025 | 11.27% |
| Mar 31, 2025 | 16.12% |
| Dec 31, 2024 | 27.66% |
| Sep 30, 2024 | 21.67% |
| Jun 30, 2024 | 21.88% |
| Mar 31, 2024 | -3.58% |
| Dec 31, 2023 | 12.87% |
| Sep 30, 2023 | -26.06% |
| Jun 30, 2023 | -47.16% |
| Mar 31, 2023 | -25.08% |